Increasing awareness, participation, funding and streamlining communication for MS trials.
7th January, 2014
The NHMRC has warned of the risks for patients seeking unproven stem cell treatments and released a new resource to assist doctors and patients.
3rd December, 2013
Clinical research does not end with the completion of the phase III clinical trials required for the registration and availability of a new drug by